Prostate Cancer - Results from #19260

Metastasis to the proximal ureter from prostatic adenocarcinoma: A rare metastatic pattern - Abstract February 17, 2015

Preoperative parameters to predict incidental (T1a and T1b) prostate cancer - Abstract February 17, 2015

Effect of dutasteride in men receiving intermittent androgen ablation therapy: The AVIAS trial - Abstract February 16, 2015

Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer - Abstract February 16, 2015

Does prostate-specific antigen nadir predict longer-term outcomes of prostate cancer after neoadjuvant and adjuvant androgen deprivation therapy in conjunction with brachytherapy? - Abstract February 16, 2015

The impact of hormonal therapy on sexual quality of life in men receiving intensity modulated radiation therapy for prostate cancer - Abstract February 16, 2015

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: Comparative effectiveness - Abstract February 14, 2015

Targeting the androgen receptor confers in vivo cross-resistance between enzalutamide and docetaxel, but not cabazitaxel, in castration-resistant prostate cancer - Abstract February 14, 2015

High-intensity focused ultrasound for the treatment of prostate cancer: A prospective trial with long-term follow-up - Abstract February 14, 2015

Risk factors for PSA bounce following radiotherapy: Outcomes from a multi-modal therapy analysis - Abstract February 14, 2015

A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer and their female partners - Abstract February 14, 2015

Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: A meta-analysis - Abstract February 14, 2015

Five-year follow-up of active surveillance for prostate cancer: A Canadian community-based urological experience - Abstract February 14, 2015

American trends in expectant management utilization for prostate cancer from 2000 to 2009 - Abstract February 14, 2015

Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic - Abstract February 14, 2015

A comprehensive review of contemporary role of local treatment of the primary tumor and/or the metastases in metastatic prostate cancer - Abstract February 14, 2015

Advances in systemic therapies for metastatic castration-resistant prostate cancer - Abstract February 13, 2015

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level - Abstract February 13, 2015

Immunotherapy in prostate cancer: Review of the current evidence - Abstract February 13, 2015

Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy - Abstract February 13, 2015

Page 964 of 1458